Centrus Energy Corp.
LEU · NYSE
Company research
Centrus Energy Corp. (NYSE: LEU) is a trusted American supplier of nuclear fuel and services for the nuclear power industry, incorporated in 1998 (formerly known as USEC Inc.) and headquartered in Bethesda, Maryland, serving utility customers across the United States, Japan, Belgium, the Netherlands, and internationally. The company operates through two segments: Low-Enriched Uranium (LEU), which sells separative work units (SWU), natural uranium hexafluoride, uranium concentrates, and enriched uranium products to nuclear power plant operators; and Technical Solutions, which provides advanced engineering, manufacturing, and operations services to government and private sector clients. Notably, Centrus is the only U.S.-licensed producer of High-Assay Low-Enriched Uranium (HALEU), operating the American Centrifuge Plant in Piketon, Ohio — the first U.S.-owned, U.S.-technology enrichment facility to commence production since 1954 — backed by a significant Department of Energy contract and a multi-billion dollar contracted backlog. With a market capitalization of approximately $3.2 billion and approximately 467 full-time employees, Centrus is at the forefront of restoring America's domestic uranium enrichment capabilities to meet clean energy, energy security, and national security needs.
Research reports
StockStory’s Q1 2026 update rates Centrus as “Underperform,” arguing the company is subscale, with weakening EBITDA and free cash flow volatility that makes its 40x forward P/E look aggressive despite a Street price target of about $278 per share. The report highlights falling margins, negative recent free cash flow, and cautions that investors can find better fundamentals at similar valuations even though consensus analyst targets are bullish.
EAA Partners · May 24, 2026CENTRUS ENERGY – From Broker to Builder: The Domestic Enrichment Wager, the 2028 Supply Cliff, and Whether the American Centrifuge Programme Can Execute Before the Policy Window ClosesEAA Partners delivers a multi-section deep dive on Centrus’s evolution from a Russian- and French-sourced LEU broker into a domestic HALEU and LEU producer, dissecting the 2028 Russian import ban, the TENEX contract economics, DOE funding, and the multi-segment business model. The author frames the investment thesis as a high-stakes industrial reconstruction that hinges on whether Centrus can execute a multi-billion-dollar enrichment buildout before its cash buffer and the current policy window run out, balancing substantial structural tailwinds against execution and policy risk.
Flash (StockSentinel.ai) · May 10, 2026Centrus Energy Corp. (LEU) Stock Research ReportFlash’s report characterizes Centrus as a “national-security champion” and the only U.S.-owned, NRC-licensed commercial enricher, detailing its LEU and Technical Solutions segments, $3.9 billion backlog, DOE HALEU task order, and Palantir-enabled cost-savings plan. It runs a full financial model with multi-scenario valuation (high, base, low cases), points to asymmetric long-term upside if the 2029 ramp and federal funding materialize, but also stresses heavy execution, regulatory, and Russian-import-cliff risks that make the near-term trajectory volatile.
Alpha Appreciation · December 4, 2025The “N of 1” Trade: Why We Buy the Centrus Pullback + closing HROW for a profitThis Substack note explains why the author is buying Centrus on a pullback, portraying LEU as the “choke point of the American nuclear renaissance” and the only domestic life support for SMR projects dependent on HALEU. It argues that the uranium supply squeeze, government dependence on Centrus, and an implied ~20% CAGR from current levels make the stock a geopolitical hedge with significant upside, while acknowledging blow-off-top price action and sector volatility as key risks.
ARMR Investing · September 11, 2025Centrus Energy Corp. (LEU) – Initiating Coverage on a Strategic U.S. Nuclear Fuel MonopolyARMR Investing’s initiating-coverage report recommends “Buy,” centering the thesis on Centrus’s transformation into a strategic HALEU monopoly and high-margin technology provider leveraged to decarbonization and AI/data-center power demand. It offers extensive fundamental analysis of revenue mix, margins, ROE/ROIC, backlog, valuation versus uranium peers and defense-like comparables, and lays out detailed bull and risk cases focusing on capital-intensive scale-up, policy dependency, and execution challenges.
Astute Investor / The Pragmatic Investor · September 1, 2025Centrus Energy: Betting on America’s Nuclear ComebackThis piece pitches Centrus as a strategic bet on a nuclear renaissance, emphasizing its unique HALEU license, position as the only U.S.-listed commercial-scale enricher, multibillion-dollar backlog, and supportive policy backdrop including executive orders targeting rapid nuclear expansion. The authors highlight asymmetric upside tied to utility and Big Tech demand for reliable baseload power and DOE contracts, while flagging dependence on government funding, long construction timelines for centrifuge capacity, competition from foreign enrichers, and uranium price swings as major risk factors.